Loading…
avatar for Rebecca Derwin

Rebecca Derwin

REGENXBIO Inc.
Senior Director, Global Product Planning
Becca Derwin is Senior Director of Global Product Planning and Portfolio Analytics at REGENXBIO, a clinical-stage gene therapy company, where she leads commercial planning for the company’s CNS and Neuromuscular gene therapy programs. Becca joined the company in 2018 from EMD Serono (Merck KGaA) where she led Global CI and Forecasting for the Neurology and Immunology Franchise, supporting the EU launch of MAVENCLAD and driving best practices in integrating CI and market insights for long-term strategic planning and prioritization. Earlier in her career, Becca spent a number of years at Genzyme in their Personalized Genetic Health Franchise learning about the potentially transformative effect treatment (and a good Pharma partner) can have on the lives of patients living with rare diseases.
Becca holds a Masters in Public Health from Tufts Medical School and a Bachelors from Worcester Polytechnic Institute. Outside of work, Becca is an Orangetheory enthusiast, a wannabe foodie and avid traveler who enjoys exploring new places.

My Speakers Sessions

Monday, September 19
 

11:45am EDT